Zurueck zur Suche

Reporte zur Charge U032676

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

11Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 2 NY 2 PA 1 TN 1 FL 1 OK 1 NV 1

VAERS 2452133

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

schwer
Staat
MI
Alter
25,0
Geschlecht
M
Eingang
20.09.2022
Impfdatum
24.03.2022
Beginn
12.09.2022
Tage bis Beginn
172,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Blood phosphorus decreased COVID-19 Condition aggravated Decreased appetite Diabetic ketoacidosis Intensive care Type 1 diabetes mellitus

Symptomtext

Discharge Provider: MD Primary Care Provider: MD Admission Date: 9/12/2022 Discharge Date: Sep 14, 2022 PRESENTING PROBLEM: DKA, type 1, not at goal (HCC) Type 1 diabetes mellitus with ketoacidosis without coma (HCC) HOSPITAL COURSE: 25-year-old female with past medical history of type 1 diabetes who was admitted to the hospital with DKA. Was also found in the ER to have acute kidney injury. After admission to the intensive care unit DKA quickly resolved with gap closure and resolution of AKI. Was also found upon arrival to have COVID diagnosis. Main symptom from COVID illness was decreased appetite but was not having any shortness of breath or other respiratory symptoms. Was felt that DKA was exacerbated from missing dose of long-acting insulin and from COVID illness. Day of discharge, patient stated was not having abdominal pain, was tolerating diet with good appetite. Phosphate day of discharge was low at 1.8. Did give IV K-Phos. Did send with 3 days of K-Phos tablets 2 times a day. Diabetes team Dr. cleared for discharge and said that he is to continue with the same previous insulin regimen. Discharged stable condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
Discharge Provider: MD Primary Care Provider at Discharge: None Physician, MD None Admission Date: 3/15/2022 Discharge Date: 3/17/2022 Active Hospital Problems Diagnosis Date Noted POA ? Diabetic ketoacidosis without coma associated with type 1 diabetes mellitus (HCC) 03/15/2022 Yes ? Lactic acidosis 03/15/2022 Yes ? AKI (acute kidney injury) (HCC) 03/15/2022 Yes ? DKA, type 1, not at goal (HCC) 11/05/2021 Yes ? Moderate protein-calorie malnutrition (HCC)
Vorgeschichte
DKA (diabetic ketoacidosis) (HCC) Type 1 diabetes mellitus with hyperglycemia (HCC) COVID-19 virus infection Hyperkalemia Elevated lipase
Andere Medikamente
Continuous Blood Gluc Sensor (FREESTYLE LIBRE 2 SENSOR SYSTM) MISC Contour Next Test Strips insulin glargine (LANTUS SOLOSTAR) 100 UNIT/ML pen-injector insulin lispro (HUMALOG KWIKPEN) 100 UNIT/ML pen-injector Insulin Pen Needle (BD ULTRA-F
Allergien
None
Vorherige Impfungen
-

VAERS 2409786

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

schwer
Staat
PA
Alter
12,0
Geschlecht
F
Eingang
12.08.2022
Impfdatum
04.08.2020
Beginn
06.08.2022
Tage bis Beginn
732,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Bell's palsy Migraine

Symptomtext

Belle's Palsy a few days after Gardasil #2 resolved in 24 hrs, had a migraine . Labs are being ordered

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
CBC, CMP, TSH, Lipid, Vitamin D, Lyme Ehrlichiosis Anaplasmosis and Babesiosis antibodies and lead levels ordered
Aktuelle Erkrankungen
Asthma, Attention deficit hyperactivity disorder, hypothryroidism
Vorgeschichte
as detailed in Item 11
Andere Medikamente
Albuterol Sulfate as needed Concerta daily Flovent twice a day Synthroid daily Ventolin Inhaler as needed
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 2393759

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

schwer
Staat
TN
Alter
18,0
Geschlecht
F
Eingang
27.07.2022
Impfdatum
27.07.2022
Beginn
27.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness Pallor

Symptomtext

after vaccination, patient became pale and also reported feeling light headed, and briefly passed out. She did not loss consciousness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
ambulance was called and emt came into clinic to assess patient. no laboratory test performed.
Aktuelle Erkrankungen
none
Vorgeschichte
mother reports patient had a hx of vagal response as a toddler.
Andere Medikamente
noen
Allergien
none
Vorherige Impfungen
-

VAERS 2252176

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

schwer
Staat
NY
Alter
11,0
Geschlecht
F
Eingang
26.04.2022
Impfdatum
22.04.2022
Beginn
22.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Crying Dental care Face injury Fall Gingival disorder Haemorrhage Lip injury Loss of consciousness Oral pain Tooth fracture

Symptomtext

Approximately 10 seconds after I gave the HPV #2 vaccine to this patient in her right deltoid, she passed out and fell off the exam table landing on the floor. she fell on the opposite side of the table of where I was landing face down on the floor. this broke a part of one of her front teeth off which also puntured her lower lip.In about 4 secconds she was totally alert, asking what happened and started crying because her mouth was sore. We had her spit out the blood that was in her mouth, removed the piece of tooth that was in her lower lip and applied a cold cloth then an ice pak. Parents were called. Dad took her to their dentist. Will receive further dental treatment in a week when the gum has firmed up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
multi vitamin with fluoride
Allergien
none
Vorherige Impfungen
-

VAERS 2213295

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

schwer
Staat
FL
Alter
38,0
Geschlecht
F
Eingang
03.04.2022
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Asthenia Dizziness Nausea Syncope Unresponsive to stimuli

Symptomtext

Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Additional Details: Patient faint for around 1 minute or less. 911 was called. Patient was countious when they arrived but was still feeling weak and had nausea. They were taking the patient to an emergency room.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2198625

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

mild
Staat
NY
Alter
17,0
Geschlecht
M
Eingang
25.03.2022
Impfdatum
03.03.2022
Beginn
24.03.2022
Tage bis Beginn
21,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Swelling Tenderness

Symptomtext

Tender, swelling area, shoulder pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2717092

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u032676

gering
Staat
OK
Alter
-
Geschlecht
U
Eingang
23.11.2023
Impfdatum
07.11.2023
Beginn
07.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

no further AE.; Pharmacist calls to report GARDASIL 9 u032676 exp 10/26/2023 was given to a patient 11/7/2023. See case 02505029. No further AE. No PQC.; This spontaneous report was received from a pharmacist and referred to a patient with unknown age and gender. The patient's concurrent conditions, concomitant therapies, historical drugs and historical conditions were not reported. On 07-NOV-2023, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, one time, lot #u032676, expiration date: 26-OCT-2023, administered for prophylaxis (strength, dose, anatomical site of administration and route of administration were not provided) (Expired vaccine used). No further adverse event (AE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2559504

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

gering
Staat
-
Alter
68,0
Geschlecht
F
Eingang
13.01.2023
Impfdatum
16.04.2022
Beginn
16.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient was given a Gardasil vaccination outside of guidelines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2446242

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

gering
Staat
MI
Alter
16,0
Geschlecht
F
Eingang
15.09.2022
Impfdatum
12.09.2022
Beginn
12.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered

Symptomtext

Hep A dose was given as an adult dose instead of a pediatric dose. Patient did not report any negative symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Ortho- Try-Cyclen
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2394905

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

gering
Staat
-
Alter
35,0
Geschlecht
F
Eingang
28.07.2022
Impfdatum
18.07.2022
Beginn
19.07.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Petechiae

Symptomtext

Patient developed petechiae on skin of lower abdomen

Weitere VAERSDATA-Felder
Praegender Schweregrund
Petechiae
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2254034

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U032676

gering
Staat
NV
Alter
12,0
Geschlecht
F
Eingang
27.04.2022
Impfdatum
15.05.2007
Beginn
11.04.2022
Tage bis Beginn
5.445,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Extra dose administered No adverse event

Symptomtext

Patient did not have any symptoms or adverse effects; Product origin unknown; Caller is a medical assistant who reports that GARDASIL 9 was given to a pregnant patient.; extra dose administered; This spontaneous prospective pregnancy report was received from a medical assistant referring to a 26-year-old female patient. the patient's concurrent conditions included gestational diabetes and hypothyroidism. The patient's concomitant therapies included acetylsalicylic acid(ASPIRINE), prenatal vitaminis and metformin. The patient's medical history and historical medications were not reported. On 15-MAY-2007, 17-JUL-2007 and 03-APR-2008, the patient was vaccinated with the 3 doses of an unknown brand of a HPV vaccine (dose, route of administration, lotnubmer and expiration date not reported) for prophylaxis (product origin unknown), and on 11-APR-2022, was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) 0.5 milliliter, intramuscular, lot number U032676, expiration date 26-OCT-2023 for immunisation (exposure during pregnancy). This dose was administered as the patient did not recall to have been given and HPV vaccine before (the dates were looked into the patient's chart) (extra dose administered). No adverse event was reported. The patient became pregnant with LMP of 19-JUL-2021 and EDD of 25-APR-2022. Initial exposure to hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) was at 38 week(s). The pregnancy outcome was outcome pending.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Gestational diabetes; Hypothyroidism; Routine immunisation
Vorgeschichte
-
Andere Medikamente
ASPIRINE; METFORMIN
Allergien
-
Vorherige Impfungen
-